1. Florian Heinen, Peter Baxter. Cerebral Palsy. In: Kennedy C, editor. Principles and Practice of Child Neurology in Infancy. Principles and Practice of Child Neurology in Infancy. 2 ed. London, UK: Mac Keith Press; 2020. p. 469-505.
2. Amoghimath R, Gowda V, Benakappa A. Comorbidities and their relationship to subtype of cerebral palsy in a tertiary care hospital in South India. Indian Journal of Cerebral Palsy. 2016;2(2):90-3.
3. Eriksson E, Hägglund G, Alriksson-Schmidt AI. Pain in children and adolescents with cerebral palsy – a cross-sectional register study of 3545 individuals. BMC Neurology. 2020;20(1):15.
4. Hagglund G, Burman-Rimstedt A, Czuba T, Alriksson-Schmidt AI. Self-versus Proxy-Reported Pain in Children with Cerebral Palsy: A Population-Based Registry Study of 3783 Children. J Prim Care Community Health. 2020;11:2150132720911523.
5. National Guideline Alliance. Cerebral palsy in under 25s: assessment and management. London: National Institute for Health and Care Excellence (UK). ; 2017 Jan. (NICE Guideline, No. 62.) 27, Other comorbidities in cerebral palsy. Available from: https://www.ncbi.nlm.nih.gov/books/NBK533230/.
6. Ostojic K, Paget SP, Morrow AM. Management of pain in children and adolescents with cerebral palsy: a systematic review. Dev Med Child Neurol. 2019;61(3):315-21.
7. Parkinson KN, Dickinson HO, Arnaud C, Lyons A, Colver A, group S. Pain in young people aged 13 to 17 years with cerebral palsy: cross-sectional, multicentre European study. Archives of disease in childhood. 2013;98(6):434-40.
8. Fairhurst C, Shortland A, Chandler S, Will E, Scrutton D, Simonoff E, et al. Factors associated with pain in adolescents with bilateral cerebral palsy. Dev Med Child Neurol. 2019;61(8):929-36.
9. Alriksson-Schmidt A, Hagglund G. Pain in children and adolescents with cerebral palsy: a population-based registry study. Acta Paediatr. 2016;105(6):665-70.
10. Hauer J, Houtrow AJ. Pain Assessment and Treatment in Children With Significant Impairment of the Central Nervous System. Pediatrics. 2017;139(6).
11. Westbom L, Rimstedt A, Nordmark E. Assessments of pain in children and adolescents with cerebral palsy: a retrospective population-based registry study. Dev Med Child Neurol. 2017;59(8):858-63.
12. Penner M, Xie WY, Binepal N, Switzer L, Fehlings D. Characteristics of pain in children and youth with cerebral palsy. Pediatrics. 2013;132(2):e407-13.
13. Baxter P. Comorbidities of cerebral palsy need more emphasis--especially pain. Dev Med Child Neurol. 2013;55(5):396.
14. Barney CC, Krach LE, Rivard PF, Belew JL, Symons FJ. Motor function predicts parent-reported musculoskeletal pain in children with cerebral palsy. Pain Res Manag. 2013;18(6):323-7.
15. Ramstad K, Jahnsen R, Skjeldal OH, Diseth TH. Characteristics of recurrent musculoskeletal pain in children with cerebral palsy aged 8 to 18 years. Dev Med Child Neurol. 2011;53(11):1013-8.
16. Chin EM, Lenz C, Ye X, Campbell CM, Stashinko E, Jantzie LL, et al. Clinical Factors Associated With Chronic Pain in Communicative Adults With Cerebral Palsy: A Cross-Sectional Study. Frontiers in Pain Research. 2020;1(6).
17. Kim E. Barrett SMB, Heddwen L. Brooks et al. Ganong's review of medical physiology. 26 ed. New York, USA: Mc-Graw Hill; 2019 January 1, 2019. 1792 p.
18. Nancy C. Tkacs, Peggy A. Compton, and Kara Pavone. Nervous System. In: Nancy C. Tkacs LLH, Randall L. Johnson, editor. Advanced Physiology and Pathophysiology. 1 ed. 11 West 42nd Street, New York, NY 10036: Springer Publishing Company, LLC; 2021. p. 1374-569.
19. Ostojic K, Paget S, Kyriagis M, Morrow A. Acute and Chronic Pain in Children and Adolescents With Cerebral Palsy: Prevalence, Interference, and Management. Arch Phys Med Rehabil. 2020;101(2):213-9.
20. Tedroff K, Gyllensvard M, Lowing K. Prevalence, identification, and interference of pain in young children with cerebral palsy: a population-based study. Disabil Rehabil. 2019:1-7.
21. Voscopoulos C, Lema M. When does acute pain become chronic? Br J Anaesth. 2010;105 Suppl 1:i69-85.
22. Blackman JA, Svensson CI, Marchand S. Pathophysiology of chronic pain in cerebral palsy: implications for pharmacological treatment and research. Dev Med Child Neurol. 2018;60(9):861-5.
23. Chanel Davidoff EL. Central Pain Syndromes. In: Sanjog Pangarkar QGP, Blessen C. Eapen, editor. Pain Care Essentials and Innovations. 3251 Riverport Lane, St. Louis, Missouri 63043, USA: Cathleen Sether, Elsevier Inc; 2021. p. 33-89.
24. Bahm J. Central Neural Plasticity. In: Bahm J, editor. Movement Disorders of the Upper Extremities in Children Conservative and Operative Therapy. 1 ed. Gewerbestrasse 11, 6330 Cham, Switzerland: Springer; 2021. p. 93-7.
25. Flor H. Maladaptive plasticity, memory for pain and phantom limb pain: review and suggestions for new therapies. Expert Rev Neurother. 2008;8(5):809-18.
26. Kuner R, Flor H. Structural plasticity and reorganisation in chronic pain. Nature Reviews Neuroscience. 2017;18(1):20-30.
27. Zochodne DW. The disrupted connectome and pain. Our Wired Nerves: The Human Nerve Connectome. 1 ed: Academic Press; 2020. p. 155-71.
28. Jonas WB, Crawford C, Colloca L, Kriston L, Linde K, Moseley B, et al. Are Invasive Procedures Effective for Chronic Pain? A Systematic Review. Pain Med. 2019;20(7):1281-93.
29. St James-Roberts I, Garratt R, Powell C, Bamber D, Long J, Brown J, et al. A support package for parents of excessively crying infants: development and feasibility study. Health Technol Assess. 2019;23(56):1-144.
30. Sacha GL, Foreman MG, Kyllonen K, Rodriguez RJ. The Use of Gabapentin for Pain and Agitation in Neonates and Infants in a Neonatal ICU. J Pediatr Pharmacol Ther. 2017;22(3):207-11.
31. Asaro J, Robinson CA, Levy PT. Visceral Hyperalgesia: When to Consider Gabapentin Use in Neonates-Case Study and Review. Child Neurol Open. 2017;4:2329048x17693123.
32. Hauer JM, Wical BS, Charnas L. Gabapentin Successfully Manages Chronic Unexplained Irritability in Children With Severe Neurologic Impairment. Pediatrics. 2007;119(2):e519-e22.
33. Hielkema T, Boxum AG, Hamer EG, Geertzen JH, Hadders-Algra M. Time to Update the Gross Motor Function Classification System (GMFCS) for Early Age Bands by Incorporation of Assisted Mobility? Pediatr Phys Ther. 2017;29(1):100-1.
34. Harb A, Kishner S. Modified Ashworth Scale. [Updated 2021 May 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554572/.
35. Fleischman AR. Children Are Special. Hard Questions, Hard Choices. In: Fleischman AR, editor. Pediatric Ethics Protecting the Interests of Children. 1 ed. Canada: Oxford University Press; 2016. p. 5-9.
36. Romito JW, Turner ER, Rosener JA, Coldiron L, Udipi A, Nohrn L, et al. Baclofen therapeutics, toxicity, and withdrawal: A narrative review. SAGE Open Med. 2021;9:20503121211022197.
37. Bax M, Tydeman C, Flodmark O. Clinical and MRI Correlates of Cerebral Palsy. The European Cerebral Palsy Study. JAMA. 2006;296(13):1602-8.
38. David Schoenfeld PD. Statistical considerations for a cross-over study where the outcome is a measurement USA2020 [Available from: http://hedwig.mgh.harvard.edu/sample_size/js/js_crossover_quant.html.
39. Indrayan A. Blinding, Concealment of Allocation, and Masking. Research Methods for Medical Graduates. 1st ed. Boca Raton, FL, USA: CRC Press, Taylor & Francis Group; 2020. p. 84-6.
40. Food and Drug Administration U. Informed Consent USA2014 [Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/informed-consent.
41. Day RO, Williams KM. Open-label extension studies: do they provide meaningful information on the safety of new drugs? Drug Saf. 2007;30(2):93-105.
42. Cohen S, Pablos JL, Pavelka K, Müller GA, Matsumoto A, Kivitz A, et al. An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis. Arthritis Res Ther. 2019;21(1):84.
43. Mansour AR, Farmer MA, Baliki MN, Apkarian AV. Chronic pain: the role of learning and brain plasticity. Restor Neurol Neurosci. 2014;32(1):129-39.
44. Franklin R. Amthor SKT, & Robert E. Sorge. Somatosensory System. In: Franklin R. Amthor, David G. Standaert, Anne B. Theibert, Erik D. Roberson, editor. Essentials of Modern Neuroscience. 1 ed. USA: McGraw-Hill Education / Medical; 2020. p. 266.
45. Benedetti F, Carlino E, Pollo A. How placebos change the patient's brain. Neuropsychopharmacology. 2011;36(1):339-54.
46. Nagabhushana Rao Potharaju, Kishan Rao B, Vishnu P H and Hymavathy M. Cerebral palsy, problems, and solutions – for India. 6th Annual Conference of Indian Academy of Neurology; 25-27th September; Hyderabad, India: Indian Academy of Neurology; 1998.
47. Li S, Shi S, Chen F, Lin J. The effects of baclofen for the treatment of gastroesophageal reflux disease: a meta-analysis of randomized controlled trials. Gastroenterol Res Pract. 2014;2014:307805.
48. Speyer R, Cordier R, Kim JH, Cocks N, Michou E, Wilkes-Gillan S. Prevalence of drooling, swallowing, and feeding problems in cerebral palsy across the lifespan: a systematic review and meta-analyses. Dev Med Child Neurol. 2019;61(11):1249-58.
49. Calis EA, Veugelers R, Sheppard JJ, Tibboel D, Evenhuis HM, Penning C. Dysphagia in children with severe generalized cerebral palsy and intellectual disability. Dev Med Child Neurol. 2008;50(8):625-30.
50. Samal P, Goyal V, Makharia GK, Das CJ, Gorthi SP, Y VV, et al. Transfer Dysphagia Due to Focal Dystonia. J Mov Disord. 2018;11(3):129-32.